Dillan Stengel

Dillan Stengel, PhD, currently serves as a Senior Scientist in Analytical Development Drug Substance at Neurocrine Biosciences, a biopharmaceutical company focused on developing treatments for under-addressed neurological disorders. Stengel's academic background includes a PhD in Chemistry from San Diego State University, where advanced research was conducted on the structure and dynamics of large intrinsically disordered proteins and spider silk proteins using sophisticated NMR techniques. Previous experience includes roles as a Research Associate II at Nucelis LLC, providing analytical support in lipid compound commercialization, and as a Biochemistry Intern at Cibus US LLC, focusing on lipid extraction and quantification methods. Additional experiences include work in the Russell Doolittle Laboratory at UCSD, and an internship at the United States Army Medical Research Institute of Chemical Defense, investigating the impact of ricin toxin on epithelial cells.